Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 62.97
-0.48 (-0.76%)
At close: Jan 22, 2026
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 8.28 billion as of January 22, 2026. Its market cap has increased by 91.62% in one year.
Market Cap
8.28B
Enterprise Value
8.08B
Revenue
1.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
62.97
Market Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 8.28B, an increase of 88.18%. That is a compound annual growth rate of 10.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 8.28B | 11.65% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghua Biological Products | 9.77B |
| Anhui Huaheng Biotechnology | 9.50B |
| Sino Biological,Inc. | 9.45B |
| Jiangxi Fushine Pharmaceutical | 9.08B |
| Daan Gene | 8.86B |
| Nanjing Vazyme Biotech | 8.62B |
| Zhejiang Ausun Pharmaceutical | 8.16B |
| Wuhan Keqian Biology Co.,Ltd | 7.68B |